Perspectives on Metastatic Kidney Cancer

EP. 1: Prognostic and Predictive Factors in Renal Cell Carcinoma

January 29th 2016

EP. 2: Treating Intermediate and Favorable-Risk RCC

January 29th 2016

EP. 3: Reviewing Results from COMPARZ and PISCES Clinical Trials

January 29th 2016

EP. 4: Dosing Sunitinib and Pazopanib in Renal Cell Carcinoma

January 29th 2016

EP. 5: Bone and Brain Metastases in Renal Cell Carcinoma

January 29th 2016

EP. 6: Treating Non-Clear Cell Renal Cell Carcinoma

January 29th 2016

EP. 7: Managing Disease Progression in RCC

January 29th 2016

EP. 8: Selecting Second-Line Agents in Renal Cell Carcinoma

January 29th 2016

EP. 9: Predictive Tools in Renal Cell Carcinoma

January 29th 2016

EP. 10: Clinical Trial Data Review: Nivolumab Use in RCC

January 29th 2016

EP. 11: Trial Data on Cabozantinib in Renal Cell Carcinoma

January 29th 2016

EP. 12: PD-L1 Expression as a Biomarker in RCC

January 29th 2016

EP. 13: Study Results: Lenvatinib in Renal Cell Carcinoma

January 29th 2016

EP. 14: Vaccines for Renal Cell Carcinoma

January 29th 2016

EP. 15: Advancing Renal Cell Carcinoma

January 29th 2016